Aclaris Therapeutics (ACRS)
Develops immunology drug candidates through biologics, kinase inhibitors, and discovery services.
$5.15
vs last close−0.58 (−10.05%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
−$0.17
Revenue estimate
$1.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$1.01−$0.12−$0.13−$0.12−$0.16−$0.15−$0.15Pending
Estimate−$0.32−$0.17−$0.13−$0.13−$0.15−$0.16−$0.16−$0.17
Surprise−215.6%+29.4%0.0%+7.7%−6.7%+6.3%+6.3%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$9.2M$1.5M$1.8M$3.3M$1.3M$2.0M$1.6MPending
Estimate$2.1M$3.6M$1.1M$2.1M$2.1M$1.3M$1.4M$1.3M
Surprise+337.1%−59.0%+56.2%+59.3%−37.5%+51.0%+17.8%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2030 | −$0.28 | — | — |
| Sep 2030 | −$0.23 | — | — |
| Jun 2030 | −$0.21 | — | — |
| Mar 2030 | −$0.20 | — | — |
| Dec 2029 | −$0.17 | — | — |
| Sep 2029 | −$0.15 | — | — |
| Jun 2029 | −$0.13 | — | — |
| Mar 2029 | −$0.10 | — | — |
| Dec 2028 | −$0.09 | — | — |
| Sep 2028 | −$0.09 | — | — |
| Jun 2028 | −$0.09 | — | — |
| Mar 2028 | −$0.09 | — | — |
| Dec 2027 | −$0.22 | — | — |
| Sep 2027 | −$0.20 | — | — |
| Jun 2027 | −$0.18 | — | — |
| Mar 2027 | −$0.18 | — | — |
| Dec 2026 | −$0.17 | — | — |
| Nov 2026 | −$0.17 | — | — |
| Aug 2026 | −$0.16 | −$0.15 | +6.3% |
| May 2026 | −$0.16 | −$0.15 | +6.3% |
| Feb 2026 | −$0.15 | −$0.16 | −6.7% |
| Nov 2025 | −$0.13 | −$0.12 | +7.7% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Oct 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2030 | −$0.28 | — | — | $2.0M | — | — | — |
| Sep 2030 | −$0.23 | — | — | $1.6M | — | — | — |
| Jun 2030 | −$0.21 | — | — | $1.6M | — | — | — |
| Mar 2030 | −$0.20 | — | — | $1.6M | — | — | — |
| Dec 2029 | −$0.17 | — | — | $1.6M | — | — | — |
| Sep 2029 | −$0.15 | — | — | $1.6M | — | — | — |
| Jun 2029 | −$0.13 | — | — | $1.6M | — | — | — |
| Mar 2029 | −$0.10 | — | — | $2.0M | — | — | — |
| Dec 2028 | −$0.09 | — | — | $2.0M | — | — | — |
| Sep 2028 | −$0.09 | — | — | $1.6M | — | — | — |
| Jun 2028 | −$0.09 | — | — | $1.6M | — | — | — |
| Mar 2028 | −$0.09 | — | — | $1.6M | — | — | — |
| Dec 2027 | −$0.22 | — | — | $1.5M | — | — | — |
| Sep 2027 | −$0.20 | — | — | $1.4M | — | — | — |
| Jun 2027 | −$0.18 | — | — | $1.4M | — | — | — |
| Mar 2027 | −$0.18 | — | — | $1.4M | — | — | — |
| Dec 2026 | −$0.17 | — | — | $1.4M | — | — | — |
| Nov 5, 2026 | −$0.17 | — | — | $1.3M | — | — | — |
| Aug 6, 2026 | −$0.16 | −$0.15 | +6.3% | $1.4M | $1.6M | +17.8% | −4.3% |
| May 7, 2026 | −$0.16 | −$0.15 | +6.3% | $1.3M | $2.0M | +51.0% | +1.7% |
| Feb 26, 2026 | −$0.15 | −$0.16 | −6.7% | $2.1M | $1.3M | −37.5% | −5.4% |
| Nov 6, 2025 | −$0.13 | −$0.12 | +7.7% | $2.1M | $3.3M | +59.3% | +0.4% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 8, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 10, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 2, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 7, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 4, 2020 | |||||||
| Aug 7, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 25, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 8, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 3, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 12, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 15, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 11, 2016 | |||||||
| May 11, 2016 | |||||||
| Mar 23, 2016 | |||||||
| Nov 18, 2015 | |||||||
| Oct 13, 2015 |